Calibrated clinical judgment in psychiatric drug trials: Beyond psychometric scales.

Luca Pani¹, Gary S Sachs², Nina R Schooler³

¹Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: Luca.Pani@unimore.it.

²Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Signant Health, Blue Bell, PA, USA.

³Department of Psychiatry and Behavioral Sciences, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA.

PubMed DOI

Abstract

Psychiatric randomised controlled trials increasingly privilege psychometric rating scales, yet bedside clinical training, remains the clinician's primary integrator of meaning, context, and change. Recent reconceptualisations describe clinical judgment as a three-stage process encompassing data collection through clinical interviewing, interpretationviaclinical reasoning, and decision making (Fav…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.